DEF: UFP Technologies Sets Date for 2025 Annual Stockholders Meeting, Outlines Key Proposals

UFP Technologies will hold its annual stockholders meeting virtually on June 4, 2025, to vote on director elections, executive compensation, auditor ratification, and other business.

Summary

• UFP Technologies, Inc. will hold its Annual Meeting of Stockholders virtually on June 4, 2025, at 10:00 a.m. Eastern Daylight Time.
• Stockholders of record as of April 11, 2025, are entitled to vote.
• The meeting will address the election of seven directors, an advisory vote on executive compensation, a vote on the frequency of future advisory votes on executive compensation, and the ratification of Grant Thornton LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
• As of April 11, 2025, there were 7,706,825 shares of Common Stock outstanding and entitled to vote.
• The proxy statement and annual report are available on the company's website.

Sentiment

Score: 7

Explanation: The document is primarily factual and procedural, outlining the agenda and proposals for the upcoming stockholders meeting. The financial performance exceeding targets is a positive sign.

Positives

• The Board of Directors is comprised of a majority of independent directors.
• The company has adopted a clawback policy for the recovery of erroneously awarded compensation.
• The company prohibits hedging of its stock by employees and directors.
• The company maintains stock ownership guidelines for named executive officers and independent directors.
• Over 90% of shares voted at the 2024 annual meeting approved the company's executive compensation on an advisory basis.

Negatives

• The CEO pay ratio is 909:1, which may be viewed negatively by some stakeholders.
• The company's executive compensation includes perquisites such as marina fees and tax preparation fees for the CEO, which may be seen as excessive by some.

Risks

• The company's ability to compete depends on its ability to retain key management personnel.
• The company's industry is fragmented across numerous competing entities.
• The rights plan, though expired, may have had the effect of rendering more difficult or discouraging an acquisition or the rights may have caused substantial dilution to a person or group that attempted to acquire us on terms or in a manner not approved by our Board of Directors.

Future Outlook

The company intends to provide stockholders with an opportunity to approve, on a nonbinding advisory basis, the compensation of the named executive officers each year at the annual meeting of stockholders, subject to the Board's review of the results of the stockholders vote with respect to Proposal No. 3.

Industry Context

The company operates in a fragmented industry, requiring a competitive compensation structure to attract and retain key management personnel.

Comparison to Industry Standards

• The Compensation Committee benchmarks executive compensation against a peer group of companies including Accuray, Inc., CryoLife, Inc. (now Artivion), OraSure Technologies, Inc., AngioDynamics Inc, Cutera, Inc., Orthofix Medical, Inc., Anika Therapeutics, Inc., DMC Global, Inc., Atrion Corp, Integer Holdings Corp, Avanos Medical, Inc. and Lantheus Holdings, Inc.
• In 2024, the Compensation Committee engaged Pearl Meyer, a national compensation consulting firm, to perform an updated comprehensive comparative market study of the compensation programs offered to peer company executives and directors, and to provide recommendations on the Companys executive compensation.
• The competitive assessment done by Pearl Meyer included a survey of the following 19 companies*: Avanos Medical, Inc, AtriCure, Inc., Integra Life Sciences Holding Corp., Integer Holdings Corporation, Glaukos Corporation, STAAR Surgical Company, Orthofix Medical, Inc., Haemonetics Corporation, Sotera Health Company, 10X Genomics, Inc., Inari Medical, Inc., Transmedics Group, Inc., Atrivion, Inc., CONMED Corporation, Novanta, Inc., Azenta, Inc., iRhythm Technologies, Inc., Osi Systems, Inc. and Alphatec Holdings, Inc.

Related Party Transactions

• In fiscal 2024, the company paid Mr. Baillys brother, John Bailly, compensation in the aggregate amount of approximately $210,986, which primarily consisted of salary and of benefits available to all employees, for services rendered to us in his capacity as Director, Corporate Estimating.

Stakeholder Impact

• The outcome of the votes will impact the composition of the Board of Directors and the company's approach to executive compensation.
• The ratification of the independent auditor ensures the integrity of the company's financial statements.
• The company's performance and governance practices affect shareholder value and investor confidence.

Next Steps

• Stockholders should review the proxy materials and vote on the proposals.
• The company will hold the Annual Meeting of Stockholders on June 4, 2025.
• The Board of Directors will consider the outcome of the advisory votes on executive compensation and its frequency when making future decisions.

Key Dates

Keywords

stockholders meeting, proxy statement, executive compensation, directors, corporate governance, audit committee, Grant Thornton, UFP Technologies